Stock 4559 ZERIA PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Zeria Pharmaceutical Co., Ltd.

Equities

4559

JP3428850006

Delayed Japan Exchange
Other stock markets
 11:30:00 28/06/2024 am IST 		5-day change 1st Jan Change
2,113 JPY +0.14% Intraday chart for Zeria Pharmaceutical Co., Ltd. +2.67% +4.76%
03/06 Zeria Pharmaceutical's Attributable Profit Soars 24.8% in Fiscal 2024 MT
09/05 Zeria Pharmaceutical Co., Ltd. Announces Year End Dividend for the Full Year Ending March 31, 2024, Payable on June 28, 2024 CI

Strengths

  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Analyst opinion has improved significantly over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • The company is in debt and has limited leeway for investment
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
ZERIA PHARMACEUTICAL CO., LTD. Stock Zeria Pharmaceutical Co., Ltd.
+4.76% 58Cr -
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.50% 4.36TCr
B-
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+28.00% 2.25TCr
B+
SANDOZ GROUP AG Stock Sandoz Group AG
+21.43% 1.57TCr -
CIPLA LIMITED Stock Cipla Limited
+18.79% 1.43TCr
B+
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+56.09% 1.27TCr
B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 678.76Cr - -
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-12.70% 647.97Cr
B+
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 572.55Cr - -
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+15.72% 567.13Cr
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 4559 Stock
  4. Ratings Zeria Pharmaceutical Co., Ltd.